Showing 19–27 of 65 results
-
AED3,400.00
The Fragile X (FMR1) Mutation Screen (L) is a genetic test designed to detect mutations in the FMR1 gene, which are associated with Fragile X syndrome, a leading cause of inherited intellectual disability and autism. This screening identifies CGG repeat expansions, distinguishing between normal, premutation, and full mutation alleles. Key benefits include early detection for informed reproductive decisions, risk assessment for carriers, and guidance for personalized medical management. Utilizing advanced molecular techniques, the test ensures high accuracy and reliability. Ideal for individuals with a family history of Fragile X or unexplained developmental delays, this screening provides critical genetic insights for proactive healthcare planning.
-
-
-
Sale!
AED4,750.00 Original price was: AED4,750.00.AED1,999.00Current price is: AED1,999.00.
Unlock your gut’s potential with our Advanced Gut Microbiome Test . Get a personalized roadmap to optimize digestion, immunity, and overall wellness through cutting-edge microbial analysis and tailored recommendations. Easy, at-home testing with science-backed results.
-
AED2,820.00
The HER-2/NEU – FISH Test is a highly precise diagnostic tool used to detect HER-2 gene amplification in breast cancer and other malignancies. Utilizing Fluorescence In Situ Hybridization (FISH) technology, it provides accurate, reliable, and early detection of HER-2 status, which is crucial for determining targeted therapy eligibility, such as Herceptin (trastuzumab) treatment. This test offers higher sensitivity and specificity compared to immunohistochemistry (IHC), reducing false-positive or false-negative results. Its rapid turnaround time and clinically validated methodology make it a gold standard for personalized cancer treatment, ensuring optimal therapeutic decisions and improved patient outcomes.
-
AED4,000.00
The **Hereditary Cancer Gene Panel (57 ACMG Genes)** is a comprehensive genetic test designed to assess inherited cancer risk by analyzing 57 clinically significant genes recommended by the **American College of Medical Genetics (ACMG)**. This panel identifies mutations linked to various hereditary cancers, including **breast, ovarian, colorectal, prostate, and pancreatic cancers**, enabling early detection and personalized risk management. Key features include **next-generation sequencing (NGS) technology** for high accuracy, expert-reviewed results, and actionable insights for **preventive care and targeted treatment strategies**. Ideal for individuals with a family history of cancer, this test empowers proactive healthcare decisions, offering **lifelong benefits through early intervention and precision medicine**.
-
AED4,000.00
The **Hereditary Cancer Panel 57 ACMG 20 HBOC & 865 Literature-Reviewed Genes** is a comprehensive genetic test designed to assess hereditary cancer risk. It analyzes **57 key genes**, including the **ACMG 20** and **HBOC-related genes**, alongside **865 literature-reviewed genes**, ensuring a thorough evaluation of cancer predisposition. This panel covers a wide range of hereditary cancers, including **breast, ovarian, colorectal, and more**, providing **clinically actionable insights** for early detection and personalized risk management. Utilizing **advanced sequencing technology**, it delivers **high accuracy and reliability**, making it an essential tool for **patients, healthcare providers, and genetic counselors**. Its unique combination of **expert-curated genes and extensive literature review** enhances diagnostic precision, setting it apart as a **cutting-edge solution for hereditary cancer risk assessment**.
-
AED4,200.00
HIGH RESOLUTION-HLA A B C DR DQ DP TYPING is an advanced genetic test that provides precise, high-resolution typing of HLA Class I (A, B, C) and Class II (DR, DQ, DP) genes. It offers unparalleled accuracy in identifying HLA alleles, making it essential for organ and stem cell transplantation, disease association studies, and immunological research. Utilizing cutting-edge sequencing technology, this test ensures detailed allele-level resolution, improving donor-recipient matching and reducing transplant rejection risks. Its comprehensive coverage and high sensitivity make it a critical tool for personalized medicine, autoimmune disease research, and pharmacogenomics.
-
